axitinib Search Results


axitinib  (MedChemExpress)
95
MedChemExpress axitinib
Axitinib, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/axitinib/product/MedChemExpress
Average 95 stars, based on 1 article reviews
axitinib - by Bioz Stars, 2026-05
95/100 stars
  Buy from Supplier
axitinib  (TargetMol)
93
TargetMol axitinib
Axitinib, supplied by TargetMol, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/axitinib/product/TargetMol
Average 93 stars, based on 1 article reviews
axitinib - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier
axitinib high selleckchem  (Selleck Chemicals)
95
Selleck Chemicals axitinib high selleckchem
Axitinib High Selleckchem, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/axitinib high selleckchem/product/Selleck Chemicals
Average 95 stars, based on 1 article reviews
axitinib high selleckchem - by Bioz Stars, 2026-05
95/100 stars
  Buy from Supplier
axitinib  (Tocris)
93
Tocris axitinib
Axitinib, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/axitinib/product/Tocris
Average 93 stars, based on 1 article reviews
axitinib - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier
axitinib  (Toronto Research Chemicals)
86
Toronto Research Chemicals axitinib
Axitinib, supplied by Toronto Research Chemicals, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/axitinib/product/Toronto Research Chemicals
Average 86 stars, based on 1 article reviews
axitinib - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier
pdgf axitinib  (Cell Signaling Technology Inc)
93
Cell Signaling Technology Inc pdgf axitinib
Targeted agents in clinical hepatocellular carcinoma studies, grouped by biologic compartment
Pdgf Axitinib, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pdgf axitinib/product/Cell Signaling Technology Inc
Average 93 stars, based on 1 article reviews
pdgf axitinib - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier
axitinib  (Thermo Fisher)
94
Thermo Fisher axitinib
Targeted agents in clinical hepatocellular carcinoma studies, grouped by biologic compartment
Axitinib, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/axitinib/product/Thermo Fisher
Average 94 stars, based on 1 article reviews
axitinib - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier
axitinib  (MultiTarget Pharmaceuticals)
90
MultiTarget Pharmaceuticals axitinib
Summary of some of the targeted therapies explored in hepatocellular carcinoma to date.
Axitinib, supplied by MultiTarget Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/axitinib/product/MultiTarget Pharmaceuticals
Average 90 stars, based on 1 article reviews
axitinib - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
axitinib  (LC Laboratories)
90
LC Laboratories axitinib
Summary of some of the targeted therapies explored in hepatocellular carcinoma to date.
Axitinib, supplied by LC Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/axitinib/product/LC Laboratories
Average 90 stars, based on 1 article reviews
axitinib - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
axitinib (2 mg/kg ip; suspended in dmso (10%), tween 341 80 (10%), and 30% captisol (80%))  (Cayman Chemical)
90
Cayman Chemical axitinib (2 mg/kg ip; suspended in dmso (10%), tween 341 80 (10%), and 30% captisol (80%))
Summary of some of the targeted therapies explored in hepatocellular carcinoma to date.
Axitinib (2 Mg/Kg Ip; Suspended In Dmso (10%), Tween 341 80 (10%), And 30% Captisol (80%)), supplied by Cayman Chemical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/axitinib (2 mg/kg ip; suspended in dmso (10%), tween 341 80 (10%), and 30% captisol (80%))/product/Cayman Chemical
Average 90 stars, based on 1 article reviews
axitinib (2 mg/kg ip; suspended in dmso (10%), tween 341 80 (10%), and 30% captisol (80%)) - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
dried polyethylene glycol-based hydrogel fiber containing axitinib  (Ocular Therapeutix)
90
Ocular Therapeutix dried polyethylene glycol-based hydrogel fiber containing axitinib
Summary of some of the targeted therapies explored in hepatocellular carcinoma to date.
Dried Polyethylene Glycol Based Hydrogel Fiber Containing Axitinib, supplied by Ocular Therapeutix, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dried polyethylene glycol-based hydrogel fiber containing axitinib/product/Ocular Therapeutix
Average 90 stars, based on 1 article reviews
dried polyethylene glycol-based hydrogel fiber containing axitinib - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


Targeted agents in clinical hepatocellular carcinoma studies, grouped by biologic compartment

Journal: JNCI Journal of the National Cancer Institute

Article Title: Radiotherapy for Hepatocellular Carcinoma: New Indications and Directions for Future Study

doi: 10.1093/jnci/djw133

Figure Lengend Snippet: Targeted agents in clinical hepatocellular carcinoma studies, grouped by biologic compartment

Article Snippet: We will briefly describe several forms of preclinical tests that are used in the study of HCC and suggest which might be most suitable for this purpose. table ft1 table-wrap mode="anchored" t5 Table 2. caption a7 Compartment Target Agents Tumor growth factors EGF Cetuximab * , erlotinib * , vandetanib * PDGF Axitinib, BIBF 1120, linifanib, MEDI-575, orantinib, preretinoin, pazopanib * , sorafenib * , sunitinib * IGF AVE 1642, BIIB 022, cixutumumab, linsitinib, MEDI-573 TGF LY2157299 HGF TAC-101 Cell signaling pathways PI3K/mTOR AZD 8055, CC-223, NVP-BEZ 235, salirasib, evorlimus * , sirolimus * , tacrolimus * MEK/ERK BAY 86-9766, isomalto oligosaccharide sulfate, PD 0325901, selumetinib JAK/STAT AZD 1480, OPB-31121 “Pro-apoptotic” Artemisinin, cantharidin analogues, fenretinide, genistein, melatonin, xanthohumol, XIAP antisense AEG 35156, fluvastatin * , simvastatin * HDAC Belinostat, panobinostat, resminostat, vorinostat * Tumor microenvironment VEGF Apatinib, axitinib, brivanib, cediranib, cabozantinib, foretinib, linifanib, nintedanib, orantinib, ramucirumab, vatalanib, bevacizumab * , pazopanib * , sorafenib * , sunitinib * , vandetanib * PDGF Axitinib, linifanib, nitedanib, orantinib, preretinoin, pazopanib * , sorafenib * , sunitinib * Other antiangiogenics AMG 386, bavituximab, PI-88, tetrathiomolybdate, lenalidomide * , thalidomide * Hypoxia Darinaparsin, TH-302 Open in a separate window *US Food and Drug Administration–approved.

Techniques: Protein-Protein interactions, Analogues

Summary of some of the targeted therapies explored in hepatocellular carcinoma to date.

Journal: Hepatic Oncology

Article Title: Systemic therapy for hepatocellular carcinoma

doi: 10.2217/hep.13.10

Figure Lengend Snippet: Summary of some of the targeted therapies explored in hepatocellular carcinoma to date.

Article Snippet: There are two ongoing Phase II trials of axitinib (potent multitarget tyrosine kinase inhibitor of VEGFR1–3, PDGF and c-KIT), in second-line treatment of patients with advanced HCC [108,109] .

Techniques: Adjuvant, Histone Deacetylase Assay